EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer BeitragOpen Access · CC BY-NC 4.0

Defining Parkinson’s Disease: Past and Future

Kristina Kulcsarova, Matej Skorvanek, Ronald B Postuma, Daniela Berg

Journal of Parkinson’s Disease · 01.10.2024 · 14 (s2) · S257-S271

DOI: 10.3233/jpd-230411 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Parkinson’s Disease, online erschienen am 14.03.2024. Verfasst von Kristina Kulcsarova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, P. J. Safarik University, Kosice, Slovak Republic. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is the second most common still relentlessly progressive neurodegenerative disorder with a long period in which the pathophysiological process is already spreading but cardinal motor symptoms are not present. This review outlines the major developments and milestones in our understanding of PD that have shaped the way we define this disorder. Past criteria and definitions of PD have been based on clinical motor manifestations enabling diagnosis of the disease only in later symptomatic stages. Nevertheless, with advancing knowledge of disease pathophysiology and aim of early disease detection, a major shift of the diagnostic paradigm is being advocated towards a biological definition similar to other neurodegenerative disorders including Alzheimer’s disease and Huntington’s disease, with the ultimate goal of an earlier, disease course modifying therapy. We summarize the major pillars of this possible approach including in vivo detection of neuronal α-synuclein aggregation, neurodegeneration and genetics and outline their possible application in different contexts of use in the frame of biological PD definition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHumansalpha-SynucleinHistory, 21st CenturyHistory, 20th Century

Stichwörter der Autor:innen

Parkinson’s diseasebiomarkersgeneticsneurodegenerationsynuclein

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Neurology, P. J. Safarik University, Kosice, Slovak Republic.
  • Department of Neurology, L. Pasteur University Hospital, Kosice, Slovak Republic.
  • Department of Clinical Neurosciences, University Scientific Park MEDIPARK, P. J. Safarik University, Kosice, Slovak Republic.
  • Department of Neurology, Montreal Neurological Institute, Montreal, Quebec, Canada.
  • Department of Neurology, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.

Zitieren

APA

Kulcsarova, K., Skorvanek, M., Postuma, R. B., & Berg, D. (2024). Defining Parkinson’s Disease: Past and Future. Journal of Parkinson’s Disease, 14(s2), S257-S271. https://doi.org/10.3233/jpd-230411

Vancouver

Kulcsarova K, Skorvanek M, Postuma RB, Berg D. Defining Parkinson’s Disease: Past and Future. Journal of Parkinson’s Disease. 2024;14(s2):S257-S271. doi:10.3233/jpd-230411

BibTeX
@article{Kulcsarova2024,
  author = {Kulcsarova, Kristina and Skorvanek, Matej and Postuma, Ronald B and Berg, Daniela},
  title = {Defining Parkinson’s Disease: Past and Future},
  journal = {Journal of Parkinson’s Disease},
  year = {2024},
  volume = {14},
  number = {s2},
  pages = {S257--S271},
  doi = {10.3233/jpd-230411}
}
Kostenlos starten →